InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (25 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
25
T+90 hit rate
32%
T+90 mean return
-5.4%
Across 34 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Browse the complete record of transactions filed by Welgus Howard G., Board Member. Director active across 1 company, notably Arcutis Biotherapeutics, Inc.. Cumulatively, 65 disclosures have been logged. Split: 0 buy · 25 sells. Total volume traded: €3.3m. History available since 3 May 2021. The latest transaction was filed on 5 June 2026 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations65 total
822 sharesCommon StockSEC:0001628280-26-044079:0
1,019 sharesCommon StockSEC:0001628280-26-044079:1
2,255 sharesCommon StockSEC:0001628280-26-044079:2
4,096 sharesCommon StockSEC:0001628280-26-044079:3
635 sharesCommon StockSEC:0001628280-26-044079:4
5,778 shares0Common StockSEC:0001628280-26-042044:0
7,144 shares@ US$22.98710.0053% mcap8.4% of flowCommon StockSEC:0001801050-26-000002:0
7,144 shares@ US$22.98710.0053% mcap8.4% of flowCommon StockSEC:0001801050-26-000002
10,000 shares@ US$23.88010.0078% mcap12.4% of flowCommon StockSEC:0001628280-26-023736
10,000 shares@ US$23.88010.0077% mcap12.4% of flowCommon StockSEC:0001628280-26-023736:0
10,000 shares@ US$25.048312.7% of flowCommon StockSEC:0001628280-26-005567
10,000 shares@ US$25.04830.0079% mcap12.7% of flowCommon StockSEC:0001628280-26-005567:0
10,000 shares@ US$28.960614.9% of flowCommon StockSEC:0001628280-26-000969
10,000 shares@ US$28.96060.0092% mcap14.9% of flowCommon StockSEC:0001628280-26-000969:0
9,538 shares@ US$1.68060.0005% mcap0.8% of flowCommon StockSEC:0001801050-25-000005:0
9,538 shares@ US$1.68060.8% of flowCommon StockSEC:0001801050-25-000005
6,110 shares0Common StockSEC:0001787306-25-000115:0
3,890 shares0Common StockSEC:0001787306-25-000115:2
6,110 shares@ US$14.29822.2% of flowCommon StockSEC:0001787306-25-000115:1
3,890 shares@ US$14.29821.4% of flowCommon StockSEC:0001787306-25-000115:3
10,000 shares@ US$14.63573.8% of flowCommon StockSEC:0001787306-25-000077:0
10,000 shares@ US$15.12364.1% of flowCommon StockSEC:0001787306-25-000054:0
10,000 shares@ US$13.00483.6% of flowCommon StockSEC:0001787306-25-000040:0
10,000 shares@ US$12.713.6% of flowCommon StockSEC:0001787306-25-000015:0
10,000 shares@ US$14.67144.1% of flowCommon StockSEC:0001787306-25-000002:0
25 of 65 declarations
About Welgus Howard G.
Public sources indicate that Howard G. Welgus, M.D., FAAD, has served on the board of directors of Arcutis Biotherapeutics since August 2020, after serving as the company’s chief medical officer from 2016 to July 2020. Arcutis also states that he is a board-certified dermatologist, spent 17 years on the faculty at Washington University as a tenured full professor, and later held leadership roles at Pfizer, Nycomed, and Verrica Pharmaceuticals. Sources: https://www.arcutis.com/leadership/howard-welgus/
